NICE INSIGHT REPORT
Cell Therapy:Market Insight, CDMO Pricing and Competitor Benchmarking
Updated Monthly
2025 CDMO pricing data for 23 clinical and commercial cell therapy development and manufacturing RFP service line items
Exhaustive directory of capabilities profiles for the top 51 CDMOs specializing in cell therapy
MSC-based cell therapy project pricing study and an exploration of non-standardized manufacturing approaches
Technical focus on CAR-T, Stem Cells, Exosomes, MSCs, and iPSC-based therapies
Key market insights for innovators, CDMOs, and investors in the cell therapy industry. Mix and match subscriptions to fit your organization's goals.
Trends & Opinions
Immediate access to Nice Insight's Cell Therapy Trends & Opinions section — our SMEs' analysis of where the market is now and where it's headed.
CDMO Pricing
Access to Nice Insight's Cell Therapy CDMO Pricing Data, including price breakdowns for over 20 distinct outsourcing RFP service line items.
CDMO Profiles & Capacity
Access to Nice Insight's Cell Therapy CDMO Directory, including capabilities for more than 50 cell therapy outsourcing organizations across North America, Europe, and Asia.
Cell Therapy Landscape
Insights into the evolving global regulatory landscape for autologous and allogeneic cell therapies.
Our Market Insight provides preclinical-through-commercial research, data and analysis from Ph.D. scientists and respected voices in biopharma.
Master the Cell Therapy Market, Preclinical through Commercial:
Competitive Benchmarking
55+ Cell Therapy CDMO Profiles
Over 800 hours of data collection and analysis from
interviews, primary research and progressive study.
